Kaneka Completes Construction of Medical Device Plant in Hokkaido

Saturday, August 31, 2024

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) opened its Tomatoh manufacturing site in the Tomakomai Tobu area of ​​Hokkaido with the aim of transforming its portfolio and expanding its business and held the opening ceremony on August 26. The Tomatoh manufacturing site is the seventh domestic business site *1 for the company and the first new one in 54 years.

The completed medical device manufacturing plant *2 at the Tomatoh manufacturing site will produce “Rheocarna™” adsorption-type blood purification devices and “Liposorber™” adsorption-type plasma purification devices. The number of patients with arteriosclerosis obliterans (ASO) *3 , which these medical devices are designed to treat, is increasing worldwide, as are diabetes, chronic kidney disease and other conditions. By securing the supply base with the new plant, we will significantly expand our medical business to meet global demand.

The factory has realized full automation of its production lines as a "smart factory" using robot technology and plans to realize a "zero energy factory" that will reduce the primary energy consumption of the factory building to zero by using our photovoltaic modules, thereby promoting sustainable manufacturing.

In the future, the Tomatoh manufacturing site will be actively used as a new production base for each activity, as well as for the expansion of the medical business.

Based on our mission of putting wellness first (“KANEKA thinks ‘Wellness First’.”), we will realize a world where advanced medical care is accessible to all and science contributes to the innovation of the global environment and our daily lives. From Tomakomai, “Kaneka, the Dream Factory” will make this vision a reality.

Participants at the opening ceremony (from left):
Yoshiro Aikawa, President, Taisei Corporation
Jun Kimura, Vice Mayor, Tomakomai
Naomichi Suzuki, Governor, Hokkaido
Kimikazu Sugawara, Chairman of the Board, Kaneka Corporation
Kazuhiko Fujii, President, Kaneka Corporation
Shigenobu Sano, Senior Executive Director, Tomatoh Co., Ltd.

  1. Domestic business sites: Takasago manufacturing site, Osaka manufacturing site, Shiga manufacturing site, Kashima manufacturing site, Tomatoh manufacturing site, Tokyo headquarters, Osaka headquarters
  2. Press release dated January 23, 2022 Kaneka Builds New Medical Device Plant in Hokkaido and Invests Ten Billion Yen to Expand Global Business
    https://www.kaneka.co.jp/en/topics/news/2022/ennr2201241.html
  3. A disease that causes arteriosclerosis where stenosis and occlusion of the artery of the lower extremities has occurred, leading to impaired blood flow (ischemia). In the early stages, the disease causes cold, numbness, and disturbance of gait. As the disease progresses to critical limb ischemia with pain and ulceration, the risk of leg amputation and death increases.

About Tomatoh Manufacturing Site
Company Name: Kaneka Corporation Tomatoh Manufacturing Site
Construction Completion: August 26, 2024
Address: 6-253 Kashiwabara, Tomakomai-city, Hokkaido
Business Description: Medical device production

The text of the press release resulting from a translation should in no way be considered official. The only version of the press release that is authoritative is that of the press release in its original language. The translation must always be compared with the source text, which will constitute precedent.

Contacts
KANEKA CORPORATION
Investor Relations and Public Relations Department
Chika Harada
Info_Pro@kaneka.co.jp




Source: businesswire.com